BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ragin C, Obikoya-Malomo M, Kim S, Chen Z, Flores-Obando R, Gibbs D, Koriyama C, Aguayo F, Koshiol J, Caporaso NE, Carpagnano GE, Ciotti M, Dosaka-Akita H, Fukayama M, Goto A, Spandidos DA, Gorgoulis V, Heideman DA, van Boerdonk RA, Hiroshima K, Iwakawa R, Kastrinakis NG, Kinoshita I, Akiba S, Landi MT, Eugene Liu H, Wang JL, Mehra R, Khuri FR, Lim WT, Owonikoko TK, Ramalingam S, Sarchianaki E, Syrjanen K, Tsao MS, Sykes J, Hee SW, Yokota J, Zaravinos A, Taioli E. HPV-associated lung cancers: an international pooled analysis. Carcinogenesis 2014;35:1267-75. [PMID: 24523449 DOI: 10.1093/carcin/bgu038] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 de Oliveira THA, do Amaral CM, de França São Marcos B, Nascimento KCG, de Miranda Rios AC, Quixabeira DCA, Muniz MTC, Silva Neto JDC, de Freitas AC. Presence and activity of HPV in primary lung cancer. J Cancer Res Clin Oncol 2018;144:2367-76. [DOI: 10.1007/s00432-018-2748-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
2 Vanner EA, Shroyer KR. Comments on "HPV and lung cancer risk: a meta-analysis" [Zhai et al., J. Clin. Virol. (in press)]. J Clin Virol 2015;63:91. [PMID: 25466494 DOI: 10.1016/j.jcv.2014.11.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Tung MC, Lin PL, Cheng YW, Wu DW, Yeh SD, Chen CY, Lee H. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2. Oncotarget 2016;7:32362-74. [PMID: 27083050 DOI: 10.18632/oncotarget.8708] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
4 Kanda Y, Osaki M, Okada F. Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction. Int J Mol Sci. 2017;18:pii: E867. [PMID: 28422073 DOI: 10.3390/ijms18040867] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
5 Nakhaie M, Charostad J, Kaydani GA, Faghihloo E. The role of viruses in adenocarcinoma development. Infect Genet Evol 2020;86:104603. [PMID: 33091575 DOI: 10.1016/j.meegid.2020.104603] [Reference Citation Analysis]
6 Li M, Deng F, Qian LT, Meng SP, Zhang Y, Shan WL, Zhang XL, Wang BL. Association between human papillomavirus and EGFR mutations in advanced lung adenocarcinoma. Oncol Lett 2016;12:1953-8. [PMID: 27602120 DOI: 10.3892/ol.2016.4847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 Yatabe Y, Dacic S, Borczuk AC, Warth A, Russell PA, Lantuejoul S, Beasley MB, Thunnissen E, Pelosi G, Rekhtman N, Bubendorf L, Mino-Kenudson M, Yoshida A, Geisinger KR, Noguchi M, Chirieac LR, Bolting J, Chung JH, Chou TY, Chen G, Poleri C, Lopez-Rios F, Papotti M, Sholl LM, Roden AC, Travis WD, Hirsch FR, Kerr KM, Tsao MS, Nicholson AG, Wistuba I, Moreira AL. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. J Thorac Oncol 2019;14:377-407. [PMID: 30572031 DOI: 10.1016/j.jtho.2018.12.005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 19.3] [Reference Citation Analysis]
8 Polo V, Pasello G, Frega S, Favaretto A, Koussis H, Conte P, Bonanno L. Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization. Oncotarget 2016;7:25050-63. [PMID: 26933818 DOI: 10.18632/oncotarget.7732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lee JE, Lee YM, Seong IO, Kang MW, Lee CS, Kim KH. No Detection of Episomal or Integrated High-Risk Human Papillomavirus in Nonsmall Cell Lung Carcinomas among Korean Population. Osong Public Health Res Perspect 2016;7:356-9. [PMID: 28053840 DOI: 10.1016/j.phrp.2016.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Akhtar N, Bansal JG. Risk factors of Lung Cancer in nonsmoker. Curr Probl Cancer 2017;41:328-39. [PMID: 28823540 DOI: 10.1016/j.currproblcancer.2017.07.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 8.2] [Reference Citation Analysis]
11 Kim Y, Pierce CM, Robinson LA. Impact of viral presence in tumor on gene expression in non-small cell lung cancer. BMC Cancer 2018;18:843. [PMID: 30134863 DOI: 10.1186/s12885-018-4748-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Zhai K, Ding J, Shi HZ. Author's reply to "comments on HPV and lung cancer risk: a meta-analysis" [J. Clin. Virol. (in press)]. J Clin Virol 2015;63:92-3. [PMID: 25532992 DOI: 10.1016/j.jcv.2014.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Yu Y, Liu X, Yang Y, Zhao X, Xue J, Zhang W, Yang A. Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development. Oncol Lett 2015;10:392-8. [PMID: 26171037 DOI: 10.3892/ol.2015.3213] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
14 Jaworek H, Koudelakova V, Slavkovsky R, Drabek J, Hajduch M. The absence of high-risk human papillomavirus in Czech non-small cell lung cancer cases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2020;164:71-6. [PMID: 30631209 DOI: 10.5507/bp.2018.079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Shikova E, Ivanova Z, Alexandrova D, Shindov M, Lekov A. Human papillomavirus prevalence in lung carcinomas in Bulgaria. Microbiol Immunol 2017;61:427-32. [PMID: 28881043 DOI: 10.1111/1348-0421.12535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zaravinos A. An updated overview of HPV-associated head and neck carcinomas. Oncotarget 2014;5:3956-69. [PMID: 24970795 DOI: 10.18632/oncotarget.1934] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 10.7] [Reference Citation Analysis]
17 Nakamura Y, Suzuki M, Ozaki S, Yokota M, Nakayama M, Hattori H, Inagaki H, Murakami S. Sinonasal inverted papilloma associated with small cell neuroendocrine carcinoma: A case report and literature review of rare malignancies associated with inverted papilloma. Auris Nasus Larynx 2019;46:641-50. [PMID: 30545727 DOI: 10.1016/j.anl.2018.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Blackman E, Campbell J, Bowen C, Delmoor E, Jean-Louis G, Noumbissi R, O'Garro Y, Richards-Waritay O, Straughter S, Tolbert V, Wilson B, Ragin C. The 4th Bi-annual international African-Caribbean Cancer Consortium conference: building capacity to address cancer health disparities in populations of African descent. Infect Agent Cancer 2014;9:35. [PMID: 26422007 DOI: 10.1186/1750-9378-9-35] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
19 Ji G, Bao T, Li Z, Tang H, Liu D, Yang P, Li W, Huang Y. Current lung cancer screening guidelines may miss high-risk population: a real-world study. BMC Cancer 2021;21:50. [PMID: 33430831 DOI: 10.1186/s12885-020-07750-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Vavalà T, Rigney M, Reale ML, Novello S, King JC. An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease. Respirology 2020;25 Suppl 2:24-36. [PMID: 33124087 DOI: 10.1111/resp.13965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Chang SY, Keeney M, Law M, Donovan J, Aubry MC, Garcia J. Detection of human papillomavirus in non-small cell carcinoma of the lung. Hum Pathol 2015;46:1592-7. [PMID: 26342243 DOI: 10.1016/j.humpath.2015.07.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
22 Liu B, Taioli E. Associations between human papillomavirus and history of cancer among U.S. adults in the National Health and Nutrition Examination Survey (2003-2010). Br J Cancer 2014;111:1448-53. [PMID: 25058348 DOI: 10.1038/bjc.2014.414] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wang X, Zhang Z, Cao H, Niu W, Li M, Xi X, Wang J. Human papillomavirus type 16 E6 oncoprotein promotes proliferation and invasion of non-small cell lung cancer cells through Toll-like receptor 3 signaling pathway. J Med Virol 2017;89:1852-60. [DOI: 10.1002/jmv.24845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Ichinose J, Shinozaki-Ushiku A, Takai D, Fukayama M, Nakajima J. Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma. Expert Rev Anticancer Ther 2016;16:403-10. [PMID: 26813704 DOI: 10.1586/14737140.2016.1147352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
25 Peña N, Carrillo D, Muñoz JP, Chnaiderman J, Urzúa U, León O, Tornesello ML, Corvalán AH, Soto-Rifo R, Aguayo F. Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells. PLoS One 2015;10:e0123029. [PMID: 25830243 DOI: 10.1371/journal.pone.0123029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
26 Raymond S, Liu B, Taioli E. Racial differences in the prevalence of oncogenic oral human papillomavirus infection types in the United States adult population. Head & Neck 2018;40:2219-27. [DOI: 10.1002/hed.25317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
27 Liu CY, Li F, Zeng Y, Tang MZ, Huang Y, Li JT, Zhong RG. Infection and integration of high-risk human papillomavirus in HPV-associated cancer cells. Med Oncol 2015;32:109. [PMID: 25750043 DOI: 10.1007/s12032-015-0560-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
28 Raymond S, Li L, Taioli E, Nash D, Liu B. The effect of the Affordable Care Act dependent coverage provision on HPV vaccine uptake in young adult women, National Health and Nutrition Examination Survey 2007-2016. Prev Med 2021;148:106536. [PMID: 33798531 DOI: 10.1016/j.ypmed.2021.106536] [Reference Citation Analysis]
29 Hussen BM, Ahmadi G, Marzban H, Fard Azar ME, Sorayyayi S, Karampour R, Nahand JS, Hidayat HJ, Moghoofei M. The role of HPV gene expression and selected cellular MiRNAs in lung cancer development. Microb Pathog 2021;150:104692. [PMID: 33301856 DOI: 10.1016/j.micpath.2020.104692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Shea S, Muñoz M, Ward SC, Beasley MB, Gitman MR, Nowak MD, Houldsworth J, Sordillo EM, Ramirez JD, Paniz Mondolfi AE. Human Papillomavirus (HPV69/HPV73) Coinfection associated with Simultaneous Squamous Cell Carcinoma of the Anus and Presumed Lung Metastasis. Viruses 2020;12:E349. [PMID: 32235715 DOI: 10.3390/v12030349] [Reference Citation Analysis]
31 Chen PM, Cheng YW, Wang YC, Wu TC, Chen CY, Lee H. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis. Neoplasia 2014;16:961-71. [PMID: 25425970 DOI: 10.1016/j.neo.2014.09.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
32 Li M, Zhang XL, Deng F, Qian LT, Meng SP, Shan WL, Wang BL. Involvement of TP53 and TP16 expression in human papillomavirus-associated non-small cell lung cancer. Oncol Lett 2016;12:3330-6. [PMID: 27900000 DOI: 10.3892/ol.2016.5087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Silva EM, Mariano VS, Pastrez PRA, Pinto MC, Nunes EM, Sichero L, Villa LL, Scapulatempo-Neto C, Syrjanen KJ, Longatto-Filho A. Human papillomavirus is not associated to non-small cell lung cancer: data from a prospective cross-sectional study. Infect Agent Cancer 2019;14:18. [PMID: 31388352 DOI: 10.1186/s13027-019-0235-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
34 He F, Xiong W, Yu F, Xiao R, Ye H, Li W, Liu Z, Hu Z, Cai L. Human papillomavirus infection maybe not associated with primary lung cancer in the Fujian population of China. Thorac Cancer 2020;11:561-9. [PMID: 31971663 DOI: 10.1111/1759-7714.13282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Rezaei M, Mostafaei S, Aghaei A, Hosseini N, Darabi H, Nouri M, Etemadi A, Neill AO, Nahand JS, Mirzaei H, Donnelly SC, Doroudian M, Moghoofei M. The association between HPV gene expression, inflammatory agents and cellular genes involved in EMT in lung cancer tissue. BMC Cancer 2020;20:916. [PMID: 32972386 DOI: 10.1186/s12885-020-07428-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
36 Crippen MM, Brady JS, Burke LA, Eloy JA, Baredes S, Park RCW. Second primary lung malignancy following head and neck squamous cell carcinoma. The Laryngoscope 2019;129:903-9. [DOI: 10.1002/lary.27422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
37 Xiong WM, Xu QP, Li X, Xiao RD, Cai L, He F. The association between human papillomavirus infection and lung cancer: a system review and meta-analysis. Oncotarget 2017;8:96419-32. [PMID: 29221217 DOI: 10.18632/oncotarget.21682] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
38 Zhai K, Ding J, Shi HZ. HPV and lung cancer risk: a meta-analysis. J Clin Virol 2015;63:84-90. [PMID: 25315992 DOI: 10.1016/j.jcv.2014.09.014] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
39 Robinson LA, Jaing CJ, Pierce Campbell C, Magliocco A, Xiong Y, Magliocco G, Thissen JB, Antonia S. Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung. Br J Cancer 2016;115:497-504. [PMID: 27415011 DOI: 10.1038/bjc.2016.213] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
40 Tsyganov MM, Pevzner AM, Ibragimova MK, Deryusheva IV, Litviakov NV. Human papillomavirus and lung cancer: an overview and a meta-analysis. J Cancer Res Clin Oncol 2019;145:1919-37. [PMID: 31236668 DOI: 10.1007/s00432-019-02960-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Ramqvist T, Ortiz-Villalon C, Brandén E, Koyi H, de Petris L, Wagenius G, Brodin O, Reuterswärd C, Dalianis T, Jönsson M, Staaf J, Lewensohn R, Planck M. Analysis of human papillomaviruses and human polyomaviruses in lung cancer from Swedish never-smokers. Acta Oncol 2020;59:28-32. [PMID: 31460811 DOI: 10.1080/0284186X.2019.1657588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]